paclitaxel has been researched along with Cholangiitis, Sclerosing in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamata, K; Komeda, Y; Kono, M; Kudo, M; Masaki, S; Minaga, K; Nagai, T; Nishida, N; Okamoto, K; Sakurai, T; Takenaka, M; Watanabe, T; Yamao, K | 1 |
| Motoo, Y | 1 |
| Matsuo, T; Nakamura, Y; Suzuki, K | 1 |
| Adler, G; Kulaksiz, H; Stephani, J; von Figura, G; Wagner, M; Wegener, M; Wolf, C | 1 |
1 review(s) available for paclitaxel and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
[A case of secondary sclerosing cholangitis caused by chemotherapy with nab-paclitaxel].
Topics: Aged; Albumins; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Female; Humans; Paclitaxel; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
3 other study(ies) available for paclitaxel and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.
Topics: Adenocarcinoma; Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cholangitis, Sclerosing; Female; Humans; Immunotherapy; Middle Aged; Nivolumab; Paclitaxel; Programmed Cell Death 1 Receptor; Ramucirumab; Stomach Neoplasms | 2019 |
Nivolumab-related Sclerosing Cholangitis in Gastric Cancer.
Topics: Cholangitis, Sclerosing; Humans; Nivolumab; Paclitaxel; Programmed Cell Death 1 Receptor; Stomach Neoplasms | 2019 |
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Female; Humans; Middle Aged; Paclitaxel | 2009 |